PIM Kinases Are a Potential Prognostic Biomarker and Therapeutic Target in Neuroblastoma. [electronic resource]
Producer: 20190618Description: 849-857 p. digitalISSN:- 1538-8514
- Animals
- Apoptosis
- Biomarkers, Tumor
- Biphenyl Compounds -- pharmacology
- CRISPR-Cas Systems
- Cell Proliferation
- Female
- Follow-Up Studies
- Humans
- Infant
- Male
- Mice
- Mice, Nude
- Neoplasm Recurrence, Local -- drug therapy
- Neuroblastoma -- drug therapy
- Neurofibromin 1 -- genetics
- Prognosis
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins c-pim-1 -- antagonists & inhibitors
- Survival Rate
- Thiazolidines -- pharmacology
- Tumor Cells, Cultured
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.